Axcella Stock Analysis


USD 2.65  0.32  13.73%   

The current price rise of Axcella Health could raise concerns from investors as the firm is trading at a share price of 2.65 on 148,983 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.19. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Axcella Health partners.
Please continue to Trending Equities.
The Axcella Health stock analysis report makes it easy to digest most publicly released information about Axcella Health and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Axcella Stock analysis module also helps to analyze the Axcella Health price relationship with some important fundamental indicators such as market cap and management efficiency.

Axcella Stock Analysis Notes

About 15.0% of the company shares are held by company insiders. The book value of Axcella Health was presently reported as 0.93. The company recorded a loss per share of 1.64. Axcella Health had not issued any dividends in recent years. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. For more info on Axcella Health please contact Bill Hinshaw at 857 320 2200 or go to

Axcella Health Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Axcella Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Axcella Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Axcella Health is way too risky over 90 days horizon
Axcella Health appears to be risky and price may revert if volatility continues
Axcella Health has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (68.48 M).
Axcella Health currently holds about 63.22 M in cash with (56.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Axcella Health has a frail financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Latest headline from Axcella Health Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID - Form 8-K -

Axcella Health Upcoming and Recent Events

Earnings reports are used by Axcella Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Axcella Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report16th of March 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End16th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Axcella Largest EPS Surprises

Earnings surprises can significantly impact Axcella Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Axcella Health SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Axcella Health prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Axcella Health investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Axcella Health specific information freely available to individual and institutional investors to make a timely investment decision.
12th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
2nd of August 2022
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
26th of May 2022
Financial Statements and Exhibits. Other Events
25th of May 2022
Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
5th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
30th of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
29th of March 2022
Unclassified Corporate Event
18th of March 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Unclassified Corporate Event. Termination of a Material Definitive Agreement

Axcella Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Axcella Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axcella Health backward and forwards among themselves. Axcella Health's institutional investor refers to the entity that pools money to purchase Axcella Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon Shares7.9 M16 M
Harbourvest Partners LlcCommon Shares4.4 M8.9 M
Vanguard Group IncCommon Shares767.2 K1.6 M
Artal Group SaCommon Shares712.5 K1.4 M
Blackrock IncCommon Shares298 K606 K
Bridgeway Capital Management LlcCommon Shares250.4 K508 K
Geode Capital Management LlcCommon Shares210.4 K427 K
Group One Trading LpCall Options3.1 KK
Note, although Axcella Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Axcella Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 90.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Axcella Health's market, we take the total number of its shares issued and multiply it by Axcella Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Axcella Profitablity

Axcella Health's profitability indicators refer to fundamental financial ratios that showcase Axcella Health's ability to generate income relative to its revenue or operating costs. If, let's say, Axcella Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Axcella Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Axcella Health's profitability requires more research than a typical breakdown of Axcella Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.85) (0.92) 
Return on Average Equity(1.54) (1.67) 
Return on Invested Capital(1.04) (1.13) 

Management Efficiency

The entity has return on total asset (ROA) of (50.41) % which means that it has lost $50.41 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (149.6) %, meaning that it created substantial loss on money invested by shareholders. Axcella Health management efficiency ratios could be used to measure how well axcella health manages its routine affairs as well as how well it operates its assets and liabilities. As of August 15, 2022, Return on Average Assets is expected to decline to -0.92. In addition to that, Return on Average Equity is expected to decline to -1.67. Axcella Health Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 57.73 Million. The current year Current Assets is expected to grow to about 74.6 M, whereas Assets Non Current are forecasted to decline to about 1.1 M.
Last ReportedProjected for 2022
Book Value per Share 0.58  0.62 
Enterprise Value over EBIT(1.00) (1.08) 
Enterprise Value over EBITDA(1.31) (1.41) 
Price to Book Value 3.70  3.46 
Tangible Assets Book Value per Share 1.51  1.56 
Enterprise Value80.3 M80.5 M
Tangible Asset Value57.7 M75.8 M

Technical Drivers

As of the 15th of August 2022, Axcella Health shows the mean deviation of 4.79, and Risk Adjusted Performance of 0.1388. Axcella Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Axcella Health, which can be compared to its rivals. Please confirm Axcella Health jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Axcella Health is priced correctly, providing market reflects its regular price of 2.65 per share. Please also double-check Axcella Health total risk alpha, which is currently at 0.3275 to validate the company can sustain itself at a future point.

Axcella Health Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Moving Average is predictive technique used to analyze Axcella Health price data points by creating a series of averages of different subsets of Axcella Health entire price series.

Axcella Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axcella Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axcella Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axcella Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Epstein David R over two months ago via Macroaxis 
Acquisition by Epstein David R of 47059 shares of Axcella Health subject to Rule 16b-3
Koziel Margaret over two months ago via Macroaxis 
Sale by Koziel Margaret of 590 shares of Axcella Health
Sekhri Paul J over two months ago via Macroaxis 
Acquisition by Sekhri Paul J of 40000 shares of Axcella Health subject to Rule 16b-3
Hendrix Martin over two months ago via Macroaxis 
Acquisition by Hendrix Martin of 40000 shares of Axcella Health subject to Rule 16b-3
Crane Robert over three months ago via Macroaxis 
Purchase by Crane Robert of 267 shares of Axcella Health
Epstein David R over three months ago via Macroaxis 
Exercise or conversion by Epstein David R of 1535 shares of Axcella Health subject to Rule 16b-3
Fehlner Paul over three months ago via Macroaxis 
Purchase by Fehlner Paul of 10471 shares of Axcella Health
Societe Des Produits Nestle Sa over three months ago via Macroaxis 
Purchase by Societe Des Produits Nestle Sa of 3141361 shares of Axcella Health
Koziel Margaret over three months ago via Macroaxis 
Sale by Koziel Margaret of 553 shares of Axcella Health
Crane Robert over three months ago via Macroaxis 
Axcella Health exotic insider transaction detected
Epstein David R over three months ago via Macroaxis 
Exercise or conversion by Epstein David R of 1534 shares of Axcella Health subject to Rule 16b-3
Koziel Margaret over six months ago via Macroaxis 
Acquisition by Koziel Margaret of 33397 shares of Axcella Health subject to Rule 16b-3

Axcella Health Predictive Daily Indicators

Axcella Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Axcella Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Axcella Health Forecast Models

Axcella Health time-series forecasting models is one of many Axcella Health's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Axcella Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Axcella Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Axcella Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Axcella shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Axcella Health. By using and applying Axcella Stock analysis, traders can create a robust methodology for identifying Axcella entry and exit points for their positions.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Current Axcella Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Axcella analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Axcella analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Axcella Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Axcella analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Axcella stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Axcella Health, talking to its executives and customers, or listening to Axcella conference calls.
Axcella Analyst Advice Details

Axcella Stock Analysis Indicators

Axcella Health stock analysis indicators help investors evaluate how Axcella Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Axcella Health shares will generate the highest return on investment. By understating and applying Axcella Health stock analysis, traders can identify Axcella Health position entry and exit signals to maximize returns.
Quick Ratio4.88
Fifty Two Week Low1.3500
Shares Short Prior Month102.64k
Average Daily Volume Last 10 Day167.12k
Average Daily Volume In Three Month65.95k
Shares Percent Shares Out0.15%
Short Percent Of Float0.45%
Forward Price Earnings-1.70
Float Shares21.47M
Fifty Two Week High4.4000
Enterprise Value To Ebitda-0.99
Fifty Day Average2.1307
Two Hundred Day Average2.1840
Please continue to Trending Equities. Note that the Axcella Health information on this page should be used as a complementary analysis to other Axcella Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Axcella Stock analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
123 M
Return On Assets
Return On Equity
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.